Selected article for: "causative agent and early stage"
Author: Singh, Vipul K.; Mishra, Abhishek; Singh, Shubhra; Kumar, Premranjan; Singh, Manisha; Jagannath, Chinnaswamy; Khan, Arshad
Title: Emerging Prevention and Treatment Strategies to Control COVID-19
  • Cord-id: 7z0badyj
  • Document date: 2020_6_23
    • ID: 7z0badyj
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has now become a serious global threat after inflicting more than 8 million infections and 425,000 deaths in less than 6 months. Currently, no definitive treatment or prevention therapy exists for COVID-19. The unprecedented rise of this pandemic has rapidly fueled research efforts to discover and develop new vaccines and treatment strategies against this novel coronavirus. W
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has now become a serious global threat after inflicting more than 8 million infections and 425,000 deaths in less than 6 months. Currently, no definitive treatment or prevention therapy exists for COVID-19. The unprecedented rise of this pandemic has rapidly fueled research efforts to discover and develop new vaccines and treatment strategies against this novel coronavirus. While hundreds of vaccines/therapeutics are still in the preclinical or early stage of clinical development, a few of them have shown promising results in controlling the infection. Here, in this review, we discuss the promising vaccines and treatment options for COVID-19, their challenges, and potential alternative strategies.

    Search related documents:
    Co phrase search for related documents
    • ace ace receptor and acute ards respiratory distress syndrome: 1, 2
    • ace ace receptor and acute lung injury: 1, 2
    • ace ace receptor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • ace ace receptor inhibitor and acute respiratory syndrome: 1
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active candidate vaccine and acute respiratory syndrome: 1